Resistance and susceptibility to Salmonella infections: Lessons from mice and patients with immunodeficiencies

Reviews and Research in Medical Microbiology

Volumn 14, Issue 2, 2003, Pages 53-62

  Mastroeni, Pietro ^b   Ugrinovic, Sanja ^c   Chandra, Anita ^a   MacLennan, Calman ^c   Doffinger, Rainer ^a   Kumararatne, Dinakantha ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NONE

Author keywords

Immunity; Immunodeficiency; Infection; Salmonella

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON GAMMA RECEPTOR CHAIN 1; INTERFERON GAMMA RECEPTOR CHAIN 2; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA1 SUBUNIT; INTERLEUKIN 15; INTERLEUKIN 18; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; B LYMPHOCYTE; BACTERIAL GROWTH; CELLULAR IMMUNODEFICIENCY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; GASTROENTERITIS; GENE; H2 GENE; HOST RESISTANCE; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; NRAMP1 GENE; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLOSIS; SEPTICEMIA; STOMACH SECRETION; TH1 CELL; TYPHOID FEVER;

EID: 0042236404     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200304000-00002     Document Type: Review

References (80)

1. Ivanhoff B. Typhoid fever, global situation and WHO recommendations. Southeast Asian J Trop Med Public Health 1995, 26(Suppl. 2):1-6.
2. Bohnoff M, Miller P. Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J Infec Dis 1962, 111:117-127.
3. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999, 286:113-117.
4. Mills DM, Bajaj V, Lee CA. A 40 kb chromosomal fragment encoding Salmonella typhimurium invasion genes is absent from the corresponding region of the Escherichia coli K-12 chromosome. Mol Microbiol 1995, 15:749-759.
5. Monack DM, Hersh D, Ghori N, Bouley D, Zychlinsky A, Falkow S. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J Exp Med 2000, 192:249-258.
6. Warren J, Mastroeni P, Dougan G, Noursadeghi M, Cohen J, Walport MJ, et al. Increased susceptibility of C1q-Deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun 2002, 70:551-557.
7. Richter-Dahlfors A, Buchan AMJ, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997, 186:569-580.
8. Yrlid U, Svensson M, Hakansson A, Chambers BJ, Ljunggren HG, Wick MJ. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun 2001, 69:5726-5735.
9. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for BCG. Cell 1993, 73:469-485.
10. Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, Luxemburger C, et aL Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis 2001, 183:1156-1560.
11. Conlan JW. Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect Immun 1997, 65:630-635.
12. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE, et al. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 2000, 192:237-248.
13. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med2000, 192:227-236.
14. Groisman EA, Parra-Lopez C, Salcedo M, Lipps CJ, Heffron F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci USA 1992, 89: 11939-11943.
15. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC, et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 2000, 287:1655-1658.
16. Mastroeni P, Arena A, Costa GB, Liberto MC, Bonina L, Hormaeche CE. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb Pathog 1991, 11:33-38.
17. Everest P, Roberts M, Dougan G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect Immun 1998, 66:3355-3364.
18. Ramarathinam L, Niesel DW, Klimpel GR. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol 1993, 150:3973-3981.
19. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, Maskell DJ, et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in 8ALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 1998, 66:4767-4776.
20. Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, Okamura H, et al. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999, 67:478-483.
21. Mastroeni P, Harrison JA, Chabalgoity JA, Hormaeche CE. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect Immun 1996, 64:189-196.
22. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TIr4 gene. Science 1998, 282:2085-2088.
23. Hormaeche CE. Dead salmonellae or their endotoxin accelerate the early course of a Salmonella infection in mice. Microb Pathog 1990, 9:213-218.
24. O'Brien AD, Metcalf ES. Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. J Immunol 1982, 129: 1349-1351.
25. Mittrucker HW, Kohler A, Mak TW, Kaufmann SH. Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol 1999, 163:6769-6776.
26. McSorley SJ, Jenkins MK. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar Typhimurium. Infect Immun 2000, 68:3344-3348.
27. Mastroeni P. Immunity to systemic Salmonella infections. Curr Mol Med 2002, 2:393-406.
28. Dunstan SJ, Stephens HA, Blackwell JM, Duc CM, Lanh MN, Dudbridge F, et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001, 183:261-268.
29. Salerno-Goncalves R, Wyant TL, Pasetti MF, Fernandez-Vina M, Tacket CO, Levine MM, et al. Concomitant induction of CD4(+) and CD8(+) T cell responses in volunteers immunized with Salmonella enterica Serovar Typhi Strain CVD 908-htrA. J Immunol 2003, 170:2734-2741.
30. Harrison JA, Villarreal-Ramos B, Mastroeni P, Demarco de Hormaeche R,Hormaeche CE. Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model. Immunology 1997, 90:618-625.
31. Lo WF, Ong H, Metcalf ES, Soloski MJ. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol 1999, 162:5398-5406.
32. Lo WF, Woods AS, DeCloux A, Cotter RJ, Metcalf ES, Soloski MJ. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nature Med 2000, 6:215-218.
33. Sinha K, Mastroeni P, Harrison J, de Hormaeche RD, Hormaeche CE. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun 1997, 65:1566-1569.
34. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G. Igh-6(-/-) (B-cell-deficient) mice fail To mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000, 68:46-53.
35. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Microb Pathog 1992, 13:477-4491.
36. Hess J, Ladel C, Miko D, Kaufmann SH. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996, 156:3321-3326.
37. Chakravortty D, Hansen-Wester I, Hensel M. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 2002, 195: 1155-1166.
38. Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002, 70:336-348.
39. Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, et al., Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 1998, 102:2035-2040.
40. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998, 280:1435-1438.
41. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 1998, 19:491-494.
42. Gotuzzo E, Frisancho O, Sanchez J, Liendo G, Carrillo C, Black RE, et al. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 1991, 151:381-382.
43. Mouy R. Chronic septic granulomatosis. Clinical and therapeutic aspects. Ann Pediatr (Paris) 1989, 36:374-378.
44. Shea JE, Hensel M, Gleeson C,Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA 1996, 93: 2593-2597.
45. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001, 413:852-856.
46. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 2001, 413: 848-852.
47. Slauch JM, Mahan MJ, Mekalanos JJ. In vivo expression technology for selection of bacterial genes specifically induced in host tissues. Methods Enzymol 1994, 235:481-492.
48. Giannella RA, Broitman BS, Zamcheck N. Salmonella enteritis. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis 1971, 16:1000-1006.
49. Kim HS, Yoon H, Minn I, Park CB, Lee WT, Zasloff M, et al. Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. J Immunol 2000, 165: 3268-3274.
50. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003, 422: 522-526.
51. Zasloff M. Trypsin, for the defense. Nature Immunol 2002, 3:508-510.
52. Weinberger M, Pizzo P. The evaluation and management of neutropenic patients with unexplained fever. In Infections in Immunocompromised Infants and Children. Edited by Patrick CC. New York: Churchill Livingstone; 1992: 338-341.
53. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984, 63:243-273.
54. Morgan BP, Walport MJ. Complement deficiency and disease. Immunol Today 1991, 12:301-316.
55. Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr 1975, 86:415-417.
56. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989, 114:555-560.
57. Mahey DCW, Brown A, Greenwood BM. Plasmodium falciparum malaria and Salmonella infection in Gambian children J Infect Dis 1987, 155:1319-1321.
58. Kaye D, Merselis JG, Jr., Hook EW. Influence of Plasmodium berghei infection on susceptibility to Salmonella infection. Proc Soc Exp Biol Med 1965, 120:810-813.
59. Landesman SH, Rao SP, Ahonkhai VI. Infections in children with sickle cell anemia. Special reference to pneumococcal and Salmonella infections. Am J Pediatr Hematol Oncol 1982, 4:407-418.
60. Anand AJ, Glatt AE. Salmonella osteomyelitis and arthritis in sickle cell disease. Semin Arthritis Rheum 1994, 24:211-221.
61. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993, 86:31-42.
62. Leen CL, Birch AD, Brettle RP, Welsby PD, Yap PL. Salmonellosis in patients with primary hypogammaglobulinaemia. J Infect 1986, 12:241-245.
63. Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 2001, 80:123-133.
64. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003, 56:12-16.
65. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131:47-54.
66. Lammas DA, Casanova JL, Kumararatne DS. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol 2000, 121:417-425.
67. Remus N, Reichenbach J, Picard C, Rietschel C, Wood P, Lammas D, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res 2001, 50:8-13.
68. Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajiar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002, 70:336-348.
69. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor betal deficiency: medical and immunological implications. J Exp Med 2003, 197:527-535.
70. Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, et al. Inherited disorders of IL-12- and IFN-gammamediated immunity: a molecular genetics update. Mol Immunol 2002, 38:903-909.
71. Hart CA, Beeching NJ, Duerden BI, Curry A, French N, Kariuki S, et al. Infections in AIDS. J Med Microbiol 2000, 49:947-967.
72. Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987, 156:998-1002.
73. Fischer A. Primary immunodeficiency diseases: natural mutant models for the study of the immune system. Scand J Immunol 2002, 55:238-241.
74. Stephan JL, Vlekova V, Le Deist F, De Saint Basile G, Donadieu J, Durandy A, et al. A retrospective single-center study of clinical presentation and outcome in 117 patients with severe combined immunodeficiency. Immunodeficiency 1993, 4:87-88.
75. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 1993, 123:921-928.
76. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nature Genet 2001, 27:277-285.
77. McCracken GH, Threlkeld N, Mize S. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA 1984, 252: 1427-1432.
78. Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with Salmonella bacteraemia. Ann Intern Med 1978, 89:931-932.
79. Black PH, Kunz KL, Swartz MN. Salmonellosis- a review of some unusual aspects. N Engl J Med 1960, 262:864-870.
80. Rocha H, Kirk JW, Hearey CD. Prolonged Salmonella bacteraemia in patients with Schistosoma mansoni infection. Arch Intern Med 1971, 128:254-257.